Show simple item record

dc.contributor.authorTran, Dena H
dc.contributor.authorGupta, Anuj
dc.contributor.authorVerceles, Avelino C
dc.contributor.authorChow, Robert D
dc.date.accessioned2021-10-21T14:19:23Z
dc.date.available2021-10-21T14:19:23Z
dc.date.issued2021-10-11
dc.identifier.urihttp://hdl.handle.net/10713/16902
dc.description.abstractSevere acute respiratory syndrome coronavirus (SARS-CoV-2) emerged from Wuhan, China, in 2019, causing coronavirus disease 19 (COVID-19) and creating a global pandemic affecting millions of people worldwide. Though COVID-19 primarily affects the pulmonary structures, deleterious effects can also occur in the cardiac system. We present a case of a patient with recurrent pericardial effusions secondary to COVID-19 infection, an unusual cardiovascular manifestation of this disease. A 47-year-old man presented with altered mental status and tested positive for COVID-19. He left against medical advice and later presented two weeks later with pleuritic chest pain associated with shortness of breath. His symptoms were attributed to a moderate- to large-sized pericardial effusion, without evidence of tamponade, as confirmed by echocardiography. The fluid was removed by pericardiocentesis; analysis was negative for malignant cells, inflammatory markers, or microbiologic studies. Reaccumulation of the fluid necessitated placement of a pericardial window, resulting in the resolution of his symptoms. There are limited case reports demonstrating the association of pericardial effusion with COVID-19 infection. The effusion is likely secondary to the inflammatory response leading to capillary leakage, resulting in pericardial fluid traversing the serous pericardium. In addition to other demonstrated cardiovascular effects, COVID-19 appears to be associated with recurrent pericardial effusion. Due to the rise in COVID-19 cases, it is essential to consider pericardial effusion as a rare but potential complication of this virus. The pericardial effusion can be the primary clinical manifestation, recurrent in nature, and potentially result in tamponade physiology.en_US
dc.description.urihttps://doi.org/10.7759/cureus.18652en_US
dc.language.isoenen_US
dc.publisherCureus, Inc.en_US
dc.relation.ispartofCureusen_US
dc.subjectcovid and hearten_US
dc.subjectcovid-19en_US
dc.subjectpericardial effusionen_US
dc.subjectpericardial windowen_US
dc.subjectsars-cov-2 (severe acute respiratory syndrome coronavirus -2)en_US
dc.titleCOVID-19 Presenting as Recurrent Pericardial Effusionen_US
dc.typeArticleen_US
dc.identifier.doi10.7759/cureus.18652
dc.identifier.pmid34659927


This item appears in the following Collection(s)

Show simple item record